EUVIMEDEUVIMED entdecken
Open Access

Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity

Szumam Liu iD, Min Ma iD, Jun Qu iD, Joshua Muia, Zhijian Wu, Quintijn Bonnez iD, Karen Vanhoorelbeke, Liang Zheng, Xinyang Zhao iD, X Long Zheng iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025

DOI: 10.1161/atvbaha.124.322249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Szumam Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine (S.L., Z.W., L.Z., X.Z., X.L.Z.), The University of Kansas Medical Center. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Arginine, Repressor Proteins, ADAM Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, 13), primarily synthesized in hepatic stellate and endothelial cells, plays a pivotal role in regulation of hemostasis by proteolytic cleavage of von Willebrand factor. Severe deficiency of plasma ADAMTS13 activity may result in thrombotic thrombocytopenic purpura, a potentially fatal blood disorder. ADAMTS13 undergoes posttranslational modifications including glycosylation, citrullination, oxidation. The present study determines the impact of arginine methylation by PRMT1 (protein arginine methyltransferase 1) on ADAMTS13 secretion and function. METHODS: Cell culture, recombinant protein, biochemical analysis, site-directed mutagenesis, and animal models were utilized. RESULTS: An inhibition of arginine methylation by a type I methyl transferase PRMT inhibitor (MS023) in HEK (human embryonic kidney) 293 cells expressing recombinant ADAMTS13 and in mice results in a significant reduction of ADAMTS13 secretion, but the secreted ADAMTS13 shows an increased specific activity; conversely, an overexpression of PRMT1 in HEK-293 cells and in transgenic mice results in an increase of ADAMTS13 secretion, but the secreted ADAMTS13 exhibits a significantly reduced specific activity. The altered ADAMTS13 activity appeared to be related to its conformational changes. LC-MS/MS (liquid chromatography with tandem mass spectrometry) identified greater than100 arginine methylation events on purified recombinant ADAMTS13. Site-directed mutagenesis performed on 5 highly conserved methylation sites (R193, R498, R692, R1123, and R1206) identifies the critical role of R1206 in ADAMTS13 function. The ADAMTS13 R1206K variant exhibits a 4- to 5-fold increase of specific activity, likely resulting from an alleviation of allosteric inhibition. CONCLUSIONS: These results demonstrate the crucial role of arginine methylation in ADAMTS13 secretion and function. Our findings may shed new light on the mechanism of allosteric regulation of ADAMTS13, which may have a therapeutic implication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein-Arginine N-MethyltransferasesArginineRepressor ProteinsADAM ProteinsHumansAnimalsHEK293 CellsMethylationADAMTS13 ProteinMutagenesis, Site-DirectedMice, TransgenicProtein Processing, Post-TranslationalMiceTransfectionEnzyme Inhibitors

Stichwörter der Autor:innen

ADAMTS13animal modelarginine methylationthrombosis

Substanzen

Protein-Arginine N-MethyltransferasesADAMTS13 ProteinArginineADAMTS13 protein, humanPRMT1 protein, humanPrmt1 protein, mouseRepressor ProteinsADAMTS13 protein, mouseADAM ProteinsEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine (S.L., Z.W., L.Z., X.Z., X.L.Z.), The University of Kansas Medical Center.
  • Institute of Reproductive Medicine and Developmental Sciences (S.L., L.Z., X.Z., X.L.Z.), The University of Kansas Medical Center.
  • Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Amherst (M.M., J.Q.).
  • Thrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, WI (J.M.).
  • Laboratory for Thrombosis Research, Kortrijk, Belgium (Q.B., K.V.).

ORCID-Profile: Szumam Liu, Min Ma, Jun Qu, Quintijn Bonnez, Xinyang Zhao, X Long Zheng

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Liu, S., Ma, M., Qu, J., Muia, J., Wu, Z., Bonnez, Q., Vanhoorelbeke, K., Zheng, L., Zhao, X., & Zheng, X. L. (2025). Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.322249

Vancouver

Liu S, Ma M, Qu J, Muia J, Wu Z, Bonnez Q, et al. Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.124.322249

BibTeX
@article{Liu2025,
  author = {Liu, Szumam and Ma, Min and Qu, Jun and Muia, Joshua and Wu, Zhijian and Bonnez, Quintijn and Vanhoorelbeke, Karen and Zheng, Liang and Zhao, Xinyang and Zheng, X Long},
  title = {Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  doi = {10.1161/atvbaha.124.322249}
}
Kostenlos starten →